Headache Treatment: 5 Practices to Avoid

To help improve patient care, The American Headache Society (AHS) recently released five practices that health care professionals and patients should avoid or question regarding headache treatment. The guidelines and considerable information about them appeared in the November-December issue of Headache.

The list was created as part of the Choosing Wisely initiative of the American Board of Internal Medicine Foundation, which stresses the importance of physician and patient conversations in improving care and eliminating unnecessary tests and procedures. The Choosing Wiselyrecommendations should not be the final word in decisions about treating headache disorders or any other condition, experts say.  Instead, they are intended to foster conversation about what is — and is not — appropriate and necessary treatment. Continue Reading



Reader’s Mail: Recommended Doses of Acetaminophen, Aspirin, Caffeine and Excedrin®

Q. Excedrin Extra Strength gelcaps each contain 250 mg. of acetaminophen, 250 mg. of aspirin and 65 mg. of caffeine. Excedrin Migraine caplets contain exactly the same amounts of each ingredient. However, the first product allows the use of eight gelcaps in 24 hours, whereas the latter only allows the use of two caplets in 24 hours. Why the difference in the allowable use of two pills of apparently the same medication? Continue Reading


Ibuprofen Effective for Many Migraineurs

About half of people with migraine who take ibuprofen (Advil®, Motrin®, etc.) will get relief, according to a systematic review of nine studies with a combined total of 4,373 participants. In the studies, just over one-fourth of those who took 400 mgs., and 20% of those who took a 200-mg. dose, were pain-free in two hours compared to 11% of people who took a placebo. Another 57% of those who took the higher dose had their pain reduced to “no worse than mild.” Nausea and other migraine-related symptoms also decreased. Continue Reading